Patent · US Active

Imidazothiadiazole derivatives

US8389554B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

MERCK PATENT GESELLSCHAFT MIT BESHRANK TER HAFTUNG · DE

Inventors

Guenter Hoelzemann · Seeheim-Jugenheim, DE
Hartmut Greiner · Darmstadt, DE
Emilie Rossignol · Thoiry, FR
Dominique Swinnen · Braine-l'Alleud, BE

Key dates

Filing date	Jul 1, 2009
Grant date	Mar 5, 2013
Priority date	—
Expiry date	Jul 1, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel imidazo[2,1-b][1,3,4]thiadiazole derivatives of formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.